Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.7%

- Check32 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2, while the study record content remains unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, with no visible change to the study record content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Study Record Versions now shows a new latest revision (v3.7.0) and removes the previous revision (v3.6.6). This reflects a platform release update.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the record history and the prior 'Revision: v3.6.5' entry was removed, reflecting an update to the platform version displayed on the page.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.